Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of CTX-100 in COPD
NCT00993707Phase 2Completed
- Start
- Nov 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CTX-100 in chronic obstructive pulmonary disease (COPD). Started Nov 2010; status: completed.
02
Drugs
CTX-100
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00993707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993707.